Research

Research at Boston Children's Hospital

The research enterprise at Boston Children’s Hospital, comprising more than 3,000 researchers, is the world’s largest at a pediatric center. Our work is fueled by a deep understanding of disease coupled with world-class discovery platforms, including genetics and genomics, gene editing, bioinformatics, proteomics, bioengineering, image analysis, multiple animal models, biobanks and disease-specific stem cell lines. We have special expertise in rare disease discovery and see large, highly diverse patient populations.

michael rogers and danielle peterse

Find a Researcher

More than 3,000 researchers & scientific staff

Find a Researcher
find a Boston Children

Research Labs

1 million square feet of research space — and growing

Find a Center or Lab
explore Boston Children

Explore Research Topics

$388 million in total research funding FY2018 — #1 NIH funding for pediatric research

Find a Topic

Going into science: Women scientists at Boston Children's offer advice to girls

We gathered women scientists from across Boston Children’s Hospital and asked them to advise girls wanting to enter the field. Hear what they had to say, and go in depth here for more wise words and a taste of what they’re investigating.

Boston Children's Hospital Innovation

BCH Innovation News @BCH_Innovation 1/20/2021 7:00:01 PM
In 2017, the first child received a drug created just for her @BostonChildrens. Her landmark case provided a bluepr… https://t.co/jwCwo8R6fD
BCH Innovation News @BCH_Innovation 1/20/2021 5:00:01 PM
“Our findings suggest widespread use of face masks may help to control #COVID19 transmission,” says… https://t.co/C3lNEeeEmm
BCH Innovation News @BCH_Innovation 1/20/2021 3:49:13 PM
RT @hepaticcellnews: In #NAFLD, are triglycerides guilty until proven innocent? 👿 👼 Drs. Ivana Semova and @SudhaBiddinger at @BostonChild…
BCH Innovation News @BCH_Innovation 1/20/2021 3:46:08 PM
RT @CDMRP: Dr. Ullrich @BostonChildrens launched a clinical trial in the #Neurofibromatosis Clinical Trials Consortium studying the efficac…
BCH Innovation News @BCH_Innovation 1/20/2021 3:00:02 PM
A structurally-engineered “decoy” ACE2 protein that binds SARS-CoV-2 200X more strongly than the body’s own ACE2 re… https://t.co/z7m7Q8YoGG
BCH Innovation News @BCH_Innovation 1/19/2021 4:00:02 PM
A #COVID19 treatment? In @NatureSMB, researchers @BostonChildrens & @BU_Tweets created and tested an engineered… https://t.co/Is1hGVOcZb
Building on our extraordinary leadership in pediatric science at Boston Children’s, we translate our findings — and those of others — to fundamentally change how disease is treated and cured.

David A. Williams, MD
Senior Vice President and Chief Scientific Officer

Powered by Translations.com GlobalLink OneLink SoftwarePowered By OneLink